HYPERION DEFI, INC. Interest Expense
HYPERION DEFI, INC. (HYPD) reported Interest Expense of $678.66 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-05-15
- HYPERION DEFI, INC. interest expense for the quarter ending 2024-03-31 was $678.66K, a 49.48% increase year-over-year.
- HYPERION DEFI, INC. interest expense for the quarter ending 2023-12-31 was $680.62K, a 24.73% decline year-over-year.
- HYPERION DEFI, INC. interest expense for the quarter ending 2023-09-30 was $679.22K, a 283.44% increase year-over-year.
- HYPERION DEFI, INC. interest expense for the quarter ending 2023-06-30 was $558.00K, a 263.67% increase year-over-year.
- HYPERION DEFI, INC. interest expense for fiscal 2023 was $2.37M, a 71.87% increase from fiscal 2022.
- HYPERION DEFI, INC. interest expense for fiscal 2022 was $1.38M, a 255.91% increase from fiscal 2021.
- HYPERION DEFI, INC. interest expense for fiscal 2021 was $387.76K, a 2175.30% increase from fiscal 2020.
- HYPERION DEFI, INC. interest expense for fiscal 2020 was $17.04K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $678.66K 10-Q · filed 2024-05-15 | $1.36M derived: sum of 2 quarters · filed 2024-05-15 | $2.04M derived: sum of 3 quarters · filed 2024-05-15 | $2.60M derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-12-31 | $680.62K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $1.36M derived: sum of 2 quarters · filed 2024-03-18 | $1.92M derived: sum of 3 quarters · filed 2024-03-18 | $2.37M 10-K · filed 2024-03-18 |
| 2023-09-30 | $679.22K 10-Q · filed 2023-11-13 | $1.24M derived: sum of 2 quarters · filed 2023-11-13 | $1.69M 10-Q · filed 2023-11-13 | $2.60M derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-06-30 | $558.00K 10-Q · filed 2023-08-11 | $1.01M 10-Q · filed 2023-08-11 | $1.92M derived: sum of 3 quarters · filed 2024-05-15 | $2.09M derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-03-31 | $454.00K 10-Q · filed 2024-05-15 | $1.36M derived: sum of 2 quarters · filed 2024-05-15 | $1.54M derived: sum of 3 quarters · filed 2024-05-15 | $1.69M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $904.25K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $1.08M derived: sum of 2 quarters · filed 2024-03-18 | $1.23M derived: sum of 3 quarters · filed 2024-03-18 | $1.38M 10-K · filed 2024-03-18 |
| 2022-09-30 | $177.14K 10-Q · filed 2023-11-13 | $330.57K derived: sum of 2 quarters · filed 2023-11-13 | $475.81K 10-Q · filed 2023-11-13 | $661.16K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $153.44K 10-Q · filed 2023-08-11 | $298.67K 10-Q · filed 2023-08-11 | $484.02K derived: sum of 3 quarters · filed 2023-08-11 | $603.23K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $145.24K 10-Q · filed 2023-05-12 | $330.59K derived: sum of 2 quarters · filed 2023-05-12 | $449.80K derived: sum of 3 quarters · filed 2023-05-12 | $527.85K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $185.35K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $304.56K derived: sum of 2 quarters · filed 2023-03-31 | $382.61K derived: sum of 3 quarters · filed 2023-03-31 | $387.76K 10-K · filed 2023-03-31 |
| 2021-09-30 | $119.21K 10-Q · filed 2022-11-14 | $197.26K derived: sum of 2 quarters · filed 2022-11-14 | $202.41K 10-Q · filed 2022-11-14 | $204.47K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $78.05K 10-Q · filed 2022-08-11 | $83.19K 10-Q · filed 2022-08-11 | $85.26K derived: sum of 3 quarters · filed 2022-08-11 | $90.20K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $5.15K 10-Q · filed 2022-05-13 | $7.21K derived: sum of 2 quarters · filed 2022-05-13 | $12.16K derived: sum of 3 quarters · filed 2022-05-13 | $18.51K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $2.06K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $7.01K derived: sum of 2 quarters · filed 2022-03-30 | $13.36K derived: sum of 3 quarters · filed 2022-03-30 | $17.04K 10-K · filed 2022-03-30 |
| 2020-09-30 | $4.95K 10-Q · filed 2021-11-12 | $11.30K derived: sum of 2 quarters · filed 2021-11-12 | $14.98K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $6.35K 10-Q · filed 2021-08-12 | $10.03K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $3.68K 10-Q · filed 2021-05-14 | |||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |